Craft

Gerresheimer

Stock Price

€81.1

2024-10-29

Market Capitalization

€3.3 B

2024-08-26

Revenue

€2 B

FY, 2024

Gerresheimer Summary

Company Summary

Overview
Gerresheimer is a company that manufactures and sells packaging products and drug delivery systems. It operates through three divisions: Plastics and Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics and Devices division offers inhalers, insulin pens, prefillable syringes, and diagnostic solutions. The Primary Packaging Glass division provides infusion, dropper, and syrup bottles, injection vials, ampoules, cartridges, etc. The Advanced Technologies division develops auto-injectors and micro pumps for the subcutaneous delivery of liquid drugs.
Type
Public
Status
Active
Founded
1864
HQ
Düsseldorf, DE | view all locations
Website
https://www.gerresheimer.com/en/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Dietmar Siemssen

    Dietmar Siemssen, Chief Executive Officer, Plastics & Devices and Advanced Technologies Division

    • Bernd Metzner

      Bernd Metzner, Chief Financial Officer

      • Axel Herberg, Chairman of the Supervisory Board

        • Karin Louise Dorrepaal, Member of the Supervisory Board

          LocationsView all

          32 locations detected

          • Düsseldorf, NRW HQ

            Germany

            Peter-Müller-Straße 3

          • Vineland, NJ

            United States

            537 Crystal Ave

          • Momignies, Wallonie

            Belgium

            Rue Mandenne 19

          • Anapolis, GO

            Brazil

            Distrito Agro-Industrial de Anápolis (D A I A)

          • Sao Paulo, SP

            Brazil

            Rua Mário Regallo Pereira, 160 - Jardim Gilda Maria

          • Sao Paulo, SP

            Brazil

            R. Victório Emmanuel Soliani, 190 - Distrito Industrial Domingos Giomi

          and 26 others

          Gerresheimer Financials

          Summary Financials

          Revenue (Q3, 2025)
          €560.7M
          Gross profit (Q3, 2025)
          €212.0M
          Net income (Q3, 2025)
          (€12.3M)
          Cash (Q3, 2025)
          €145.9M
          EBIT (Q3, 2025)
          €6.0M
          Enterprise value
          $5.3B

          Footer menu